Bill

Bill > S526


NJ S526

NJ S526
Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.


summary

Introduced
01/14/2020
In Committee
02/24/2021
Crossed Over
11/16/2020
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill requires health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program, to provide coverage for insulin for the treatment of diabetes. The bill also requires health insurers (health, hospital and medical service corporations, commercial individual and group health insurers; health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to limit the copayment that may be required for an insulin prescription to $100 per 30 day supply of insulin.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (8)

Last Action

Recommitted to Assembly Appropriations Committee (on 03/17/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...